However, there is a rich history in understanding the use of adjuvants (e.g., cytokines such as interferon and GM-CSF, mycobacterial protein components, dendritic cells) in vaccine therapy in the treatment of melanoma patients [67]. This evidence concerns the gene CSF2 and melanoma.